# Formel Skin

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/formel-skin

- Industry: Healthcare Specialists
- Headquarters: Berlin, Germany
- Website: www.formelskin.de/
- Total disclosed funding: $40M
- Latest round: Series A (Dec 14, 2021)
- Investors on record: 5

## About

Formel Skin Derma GmbH is a skincare company specializing in personalized dermatological treatments tailored to individual skin needs, operating through a telemedicine platform to enhance patient accessibility and convenience.Founded in 2020 and headquartered in Berlin, Germany, Formel Skin Derma GmbH focuses on delivering personalized skincare solutions. The company's founders include Anton Kononov, Florian Semler, and Sarah Bechstein. Formel Skin has successfully completed a total of 3 deals, with its latest funding round being a Series A in December 2021, raising EUR 30.000 mn led by Singular, with participation from Cherry Ventures, Heal Capital, Heartcore Capital, and Vorwerk Ventures. This funding marks the total amount raised by the company at EUR 30.000 mn.FORMEL SKIN specializes in personalized skincare solutions tailored to individual skin needs. The company offers a range of dermatologically tested products to address skin concerns, including acne, rosacea, and pigmentation issues. Each patient receives a personalized treatment plan from licensed dermatologists based on their unique conditions, with results typically observable within 6-8 weeks. The service operates through a telemedicine platform, allowing patients to consult medical professionals remotely, facilitating easy access to skincare solutions. FORMEL SKIN primarily serves customers in Germany and Switzerland, ensuring direct delivery of products to consumers' homes for convenience and accessibility.Formel Skin generates revenue by offering personalized dermatological treatments through a subscription-based model. Customers pay a recurring monthly fee for customized skincare products and medical consultations, which are billed according to Germany’s medical fee schedule.

## Funding rounds

- Series A, Dec 14, 2021, $34M — Heartcore Capital, Vorwerk Ventures, Cherry Ventures, Heal Capital, Singular
- Seed, Dec 6, 2020, $6.1M — Heartcore Capital, Vorwerk Ventures, Cherry Ventures

## Investors

- Heartcore Capital (https://capitalatlas.ai/funds/heartcore-capital) — Seed, Series A
- Vorwerk Ventures (https://capitalatlas.ai/funds/vorwerk-ventures) — Seed, Series A
- Cherry Ventures (https://capitalatlas.ai/funds/cherry-ventures) — Seed, Series A
- Heal Capital (https://capitalatlas.ai/funds/heal-capital) — Series A
- Singular (https://capitalatlas.ai/funds/singular) — Series A